Treatment of type 2 diabetes and outcomes in patients with heart failure: a nested case-control study from the U.K. General Practice Research Database
about
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - SummaryCongestive heart failure and diabetes mellitus: balancing glycemic control with heart failure improvementCellular and molecular mechanisms of metformin: an overviewAfter avandia: the use of antidiabetic drugs in patients with heart failureShould antidiabetic treatment of type 2 diabetes in patients with heart failure differ from that in patients without?New promises for metformin: advances in the understanding of its mechanisms of actionPharmacotherapy for comorbidities in chronic heart failure: a focus on hematinic deficiencies, diabetes mellitus and hyperkalemia.A valuable approach to the use of electronic medical data in primary care research: Panning for gold.Changes in labelling for metformin use in patients with type 2 diabetes and heart failure: documented safety outweighs theoretical risks.Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes.Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver Disease: A Systematic Review.Prescribing attitudes, behaviors and opinions regarding metformin for patients with diabetes: a focus group study.Noncardiac comorbidities and acute heart failure patients.Wrongfully accused: metformin use in heart failure.Novel therapeutic targets for the treatment of heart failure.Clinical management of elderly patients with type 2 diabetes mellitus.Association of sulphonylurea treatment with all-cause and cardiovascular mortality: a systematic review and meta-analysis of observational studies.Observational studies of the association between glucose-lowering medications and cardiovascular outcomes: addressing methodological limitations.Addressing limitations in observational studies of the association between glucose-lowering medications and all-cause mortality: a review.Management of Noncardiac Comorbidities in Chronic Heart Failure.Korean Guidelines for Diagnosis and Management of Chronic Heart Failure.Chronic metformin associated cardioprotection against infarction: not just a glucose lowering phenomenon.Efficacy and safety of metformin in the management of type 2 diabetes mellitus in older adults: a systematic review for the development of recommendations to reduce potentially inappropriate prescribing.Examining risk factor goal attainment and adherence to treatment among US heart failure patients: the National Health and Nutrition Examination Survey 2007-2010.Exploring heart failure events in contemporary cardiovascular outcomes trials in type 2 diabetes mellitus.Treating Disease Mechanisms in Patients With Heart Failure and Diabetes Mellitus.Comorbidities in Heart Failure.Still sour about lactic acidosis years later: role of metformin in heart failure.Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure.Metabolic Effects of Metformin in the Failing Heart
P2860
Q22241786-E906D13A-6696-414E-92DA-125EFA69681EQ27003819-8BC331E1-82E4-4393-95C7-36BC08FD799FQ27013561-CADC722A-BA1B-4129-8CA6-A924464B3BF9Q27021166-4D41FDB4-598B-4E2B-9E98-1BC821CEFD32Q27022813-07CB6485-9C85-420E-94E7-E3DC36FA1B10Q27023545-B6C63B37-2284-4813-9EE9-843AF0A35FEDQ30250020-F3364386-98F0-4BE2-BC51-53B67EFC18B6Q31136299-D3653B11-A3A3-44E4-8C51-90D6A2A48559Q35496697-8934A277-48E7-4EDD-9252-954D37FC7CB7Q35927578-3735E2CE-FEE1-4B66-BD4B-E34ACA6D68EBQ36240156-5FC7C13B-1AF0-4C53-82C4-DE350EDA5632Q37196371-60DD6AFC-C061-46D2-83E2-7AEFDB07AD05Q37531314-7D478487-84A0-4C02-9FEB-E7C3ECF9EF57Q37859779-ED42363B-9967-4832-9333-73D46BA05B7CQ37893956-B90FF677-266F-47EA-A4F4-02AF38CE4FC2Q37982214-1FE66F4E-8CAE-4705-9CC8-CD1649087FCAQ38071847-9C391206-9E91-4DF8-A36C-4F5661B5C22FQ38248399-D9EFEC55-44A8-4417-AF36-296AB426BB91Q38374279-BCA71C6F-A50E-482B-B3EA-9711B8B97205Q38537053-1DD2EA6B-C086-4FD3-BF2C-6C9779A5EA4EQ41686228-003F189A-EE68-44C9-B059-7BD91D79D7EEQ42516922-1BA3AAAF-0298-4285-AE7E-ED4DD8662D0AQ42676651-07D3BA91-4FE8-48AD-B85D-CDB7217368C4Q46973488-06019159-75C8-483C-B32C-A3761F80BCE1Q47214520-966ED052-F1C0-4984-8624-F81FB5D057D4Q47672213-239CB4C3-DA61-49C9-9AEA-B00D4305BFDCQ47744924-D500FF35-A954-41DF-BCD2-4BE26046DA7BQ48134998-0076CA95-EC08-4E82-9896-F60A00FA8FBCQ51373277-619F4ECD-DEFB-4F26-B8B6-94744F892225Q59138235-A8774CAA-5F06-47FA-AA0A-35A43FB0CD56
P2860
Treatment of type 2 diabetes and outcomes in patients with heart failure: a nested case-control study from the U.K. General Practice Research Database
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Treatment of type 2 diabetes a ...... ral Practice Research Database
@ast
Treatment of type 2 diabetes a ...... ral Practice Research Database
@en
type
label
Treatment of type 2 diabetes a ...... ral Practice Research Database
@ast
Treatment of type 2 diabetes a ...... ral Practice Research Database
@en
prefLabel
Treatment of type 2 diabetes a ...... ral Practice Research Database
@ast
Treatment of type 2 diabetes a ...... ral Practice Research Database
@en
P2093
P2860
P356
P1433
P1476
Treatment of type 2 diabetes a ...... ral Practice Research Database
@en
P2093
Dean T Eurich
Finlay A McAlister
James D Lewsey
John J V McMurray
John R Petrie
Mark C Petrie
Michael R MacDonald
Sumit R Majumdar
P2860
P304
P356
10.2337/DC09-2227
P407
P577
2010-03-18T00:00:00Z